510(k) Implied Use Concerns Should Be Raised Early In Review Process - HIMA
This article was originally published in The Gray Sheet
FDA needs to alert a 510(k) sponsor immediately if the agency suspects that the device will be used for claims other that those sought in labeling, the Health Industry Manufacturers Industry says in May 26 comments to FDA.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.